Signs of efficacy of new targeted agents and immunotherapies for multiple cancers
Pipeline of cell and gene therapies holds promise for repairing the Parkinson’s-damaged brains
24 September 2021Survivors of domestic violence at an increased risk of contracting COVID-19
24 September 2021Signs of efficacy of new targeted agents and immunotherapies for multiple cancers
Data from early clinical trials presented at the ESMO Congress 2021 suggest that new anticancer treatments are on the horizon, with a clear emphasis on precision medicine. Despite medical research suffering setbacks in the early days of the COVID-19 pandemic, the wealth of promising new agents and innovative therapeutic approaches currently in development is evidence that the oncology field is once again looking towards the future, closing the annual rendez-vous of the oncology community with a message of hope.
